ARBOR ASSAYS

Since 1997 IBL-America has been a supplier of in-vitro diagnostic kits, antibodies and proteins for the medical device industry as well as the medical research industry. IBL-America is active in the following areas: autoimmune, brain research, endocrinology, infectious disease, neuroscience, oncology and tumor markers. IBL-America has its own technical support staff and works in conjunction with its sister company, KMI Diagnostics, to provide expert technical service and customer support. KMI Diagnostics, Inc.(www.kmidiagnostics.com) is a CLIA certified endocrinology and research laboratory specializing in hormone and neurotransmitter testing as well as correlation studies and pre-clinical trials.

Amarex is a global, full-service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs (FDA Applications and meetings, Applications to International Health Authorities, GxP Compliance Audits), Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management, Medical Monitoring, Safety and Pharmacovigilance, and General Consulting. Amarex can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application. Join our growing list of clients with approved products. Amarex provides high quality and cost efficient services.

Sign-up to receive invites to webinars, training courses and the latest cutting-edge information on clinical trials: https://go.pardot.com/l/129231/2020-07-27/39ng9k

While others are getting up to speed, DSP is getting results.

DSP Clinical is an award-winning, comprehensive CRO that delivers three distinct advantages — dedicated experts, straightforward pricing, and a perfect partnership. With a track record for getting drugs to market faster, DSP has managed more than 200 clinical trials in Phases I through IV across various therapeutic areas and has filed 24 regulatory submissions including NDAs, 510(k)s and PMAs.

Whether we are managing the entire study from start to finish or providing individual services, DSP’s global capabilities drive top-tier success for small to midsize pharmaceutical companies through unmatched experience, passionate leadership, aggressive strategies, and operational excellence.

We provide on-demand management and monitoring services that instantly scale to fit the size, complexity, and speed of your research study. Our extensive expertise covers a wide range of therapeutic areas that include reproductive endocrinology and infertility, urology, and gastrointestinal studies.

DSP takes a proactive, meticulous approach to customer studies and services. We understand customer needs and won’t settle for anything less than precision and accuracy for your clinical trial.

At DSP, we provide an effortless contracting process with fixed pricing, integrated budgeting, and no long-term contracts to simplify service delivery and minimize overhead. We identify and resolve potential study issues early and strategically allocate resources to ensure project completion on time and on budget. Our proven internal SOPs and QA metrics ensure that quality systems are in place and rigorously followed during every customer’s clinical study.

As a result of sustained company growth, we have ranked prominently on the Inc. 500/5000 list multiple times.

That’s a difference you can see. Distinctly DSP.

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,900 people across 40 countries.

Syneos Health® is the only fully integrated end-to-end clinical and commercial solution organization. We are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. Our business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.